Similar content being viewed by others Background Type 2 diabetes mellitus (T2DM), a common metabolic disorder characterized by insulin resistance and inadequate insulin secretion by pancreatic cells, has become a growing cause of morbidity and mortality worldwide
Randomly assigned groups received one of three doses 3 mg, 12 mg, 36 mg or a placebo once a day for 40 weeks
When members enroll, theyre placed into one of three care pathways based on their eligibility, medical history, and current GLP-1 usage
The peptide also demonstrates cytoprotective effects, reducing oxidative stress and preserving mitochondrial integrity during tissue injury
comes with a price but promos are ran often
Another way to stack these treatments is to alternate them